ResearcherUniversity of PittsburghActive in the last 2 years

Jing Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1849-4550; OpenAlex author ID A5114348146; NIH RePORTER profile ID 7927236. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant

Papers 1

PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin Y654. Last author DOI 10.1016/j.jcmgh.2019.07.004 ↗

Grants 1

Targeting PYK2 for the treatment of PDAC R01CA236965 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Farzad Esni · 1 shared paper, 2019 · strength 0.09
- Paper PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphor… DOI 10.1016/j.jcmgh.2019.07.004 ↗
Chenxi Gao · 1 shared paper, 2019 · strength 0.09
- Paper PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphor… DOI 10.1016/j.jcmgh.2019.07.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.